Halper Sadeh LLC's Shareholder Investigation Includes RGLS, KRON, PPBI, COEP

Overview of the Investigation

Halper Sadeh LLC, an established law firm specializing in investor rights, is currently conducting investigations into multiple public companies for potential violations of federal securities regulations and breaches of fiduciary duties owed to their shareholders. The focus of this investigation includes Regulus Therapeutics Inc. (NASDAQ: RGLS), Kronos Bio, Inc. (NASDAQ: KRON), Pacific Premier Bancorp, Inc. (NASDAQ: PPBI), and Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP).

Details of Each Company

1. Regulus Therapeutics Inc. (RGLS): Regulus is reportedly in discussions regarding its sale to Novartis AG. If completed, shareholders of Regulus will receive a cash payment of $7.00 per share, along with the potential for additional compensation based on regulatory milestones related to their lead product candidate, farabursen. This structure raises questions regarding whether shareholders are receiving fair treatment and whether all material disclosures about the sale have been made.

2. Kronos Bio, Inc. (KRON): Kronos is also facing scrutiny following its proposed acquisition by Concentra Biosciences, LLC, where shareholders stand to receive $0.57 per share in cash along with a non-tradable contingent value right. This transaction raises concerns regarding whether shareholders are being adequately compensated for their investments.

3. Pacific Premier Bancorp, Inc. (PPBI): Pacific Premier's sale to Columbia Banking System, Inc. is another point of interest for Halper Sadeh. Under the proposed terms, Pacific shareholders would exchange their shares for 0.9150 of a share of Columbia's common stock for each share owned. Investigators are evaluating if this transaction is fair and in the best interest of shareholders.

4. Coeptis Therapeutics Holdings, Inc. (COEP): Lastly, Coeptis is undergoing a merger with Z Squared Inc. This merger is yet another situation where shareholders may have questions about their rights and the ramifications of the transaction.

Legal Rights and Considerations

Halper Sadeh LLC is committed to ensuring that shareholders have their voices heard and their rights protected. The firm may pursue increased monetary considerations for shareholders, demand more comprehensive disclosures regarding these transactions, or explore other legal remedies that can provide relief or benefits to affected shareholders. Importantly, the firm operates on a contingency basis, meaning shareholders may not have to bear any upfront legal costs for these actions.

How Shareholders Can Respond

Affected shareholders are encouraged to reach out to Halper Sadeh LLC to discuss their options. They offer complimentary consultations to evaluate individual cases and determine how best to approach the situation legally. Those interested in understanding their rights and options can contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or reach out via email.

Conclusion

Halper Sadeh LLC aims to advocate for investors affected by potential corporate misconduct. As it conducts these investigations into RGLS, KRON, PPBI, and COEP, it emphasizes transparency, accountability, and the protection of shareholder interests in today's complex financial landscape. Investors should keep a close eye on these developments and consider legal action where appropriate, to ensure their rights are upheld and their financial interests are secured.